Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
5.10
Dollar change
-0.17
Percentage change
-3.23
%
IndexRUT P/E- EPS (ttm)-2.88 Insider Own23.84% Shs Outstand81.97M Perf Week-4.32%
Market Cap428.25M Forward P/E- EPS next Y-2.92 Insider Trans0.37% Shs Float63.95M Perf Month-14.72%
Income-196.83M PEG- EPS next Q-0.68 Inst Own77.29% Short Float29.26% Perf Quarter-60.80%
Sales16.05M P/S26.68 EPS this Y15.18% Inst Trans21.99% Short Ratio13.70 Perf Half Y-63.20%
Book/sh6.96 P/B0.73 EPS next Y-10.23% ROA-28.80% Short Interest18.71M Perf Year-74.37%
Cash/sh7.22 P/C0.71 EPS next 5Y- ROE-36.03% 52W Range4.90 - 21.04 Perf YTD-63.41%
Dividend Est.- P/FCF- EPS past 5Y-67.06% ROI-30.44% 52W High-75.76% Beta1.85
Dividend TTM- Quick Ratio19.82 Sales past 5Y126.44% Gross Margin41.59% 52W Low4.08% ATR (14)0.37
Dividend Ex-Date- Current Ratio19.82 EPS Y/Y TTM8.45% Oper. Margin-1381.45% RSI (14)33.53 Volatility5.42% 5.85%
Employees255 Debt/Eq0.13 Sales Y/Y TTM379.79% Profit Margin-1226.43% Recom1.36 Target Price26.89
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q30.31% Payout- Rel Volume0.97 Prev Close5.27
Sales Surprise170.39% EPS Surprise15.89% Sales Q/Q305.63% EarningsMay 08 BMO Avg Volume1.37M Price5.10
SMA20-4.93% SMA50-17.27% SMA200-53.91% Trades Volume1,329,339 Change-3.23%
Date Action Analyst Rating Change Price Target Change
Apr-08-24Initiated H.C. Wainwright Buy $15
Apr-13-23Initiated Canaccord Genuity Buy $29
Feb-01-23Initiated Cantor Fitzgerald Neutral $21
Dec-15-22Initiated Goldman Sell $13
Oct-06-22Initiated Credit Suisse Neutral $48
Aug-25-22Upgrade Stifel Hold → Buy $32 → $56
Jun-17-22Initiated BMO Capital Markets Outperform $48
Feb-18-22Initiated RBC Capital Mkts Outperform $42
Sep-24-21Initiated Stifel Hold $58
Jul-12-21Initiated William Blair Outperform $92
May-31-24 04:01PM
07:00AM
May-30-24 04:01PM
May-17-24 06:27AM
May-12-24 04:00PM
01:54PM Loading…
May-08-24 01:54PM
08:10AM
07:10AM
07:00AM
May-07-24 07:20AM
07:00AM
May-03-24 04:01PM
Apr-19-24 10:30AM
Apr-06-24 09:50AM
Apr-03-24 01:40PM
04:04PM Loading…
Apr-02-24 04:04PM
10:36AM
09:31AM
09:01AM
07:35AM
07:00AM
07:00AM
03:03AM
Mar-28-24 04:51PM
Mar-21-24 04:19PM
Mar-01-24 04:01PM
Feb-27-24 07:02PM
08:03AM
07:30AM
Feb-19-24 04:08PM
06:05AM Loading…
Feb-13-24 06:05AM
Feb-12-24 08:30AM
Feb-01-24 06:30AM
Jan-31-24 12:28PM
Jan-17-24 12:04PM
Jan-11-24 04:38PM
Jan-04-24 08:00AM
Jan-02-24 06:30AM
Dec-29-23 12:00PM
09:55AM
Dec-13-23 09:55AM
Dec-06-23 12:31PM
Dec-01-23 04:00PM
Nov-28-23 10:37PM
04:01PM
Nov-27-23 09:55AM
Nov-20-23 04:26PM
Nov-17-23 03:41PM
Nov-16-23 05:41AM
05:20AM
Nov-13-23 07:20PM
04:03PM
02:28PM
12:17PM
12:07PM
08:56AM
Nov-12-23 03:30PM
10:34AM
Nov-09-23 09:55AM
08:00AM
05:57AM
Nov-07-23 07:56AM
06:36AM
06:30AM
Nov-06-23 08:02AM
Nov-01-23 07:06AM
05:40AM
Oct-31-23 07:09PM
04:04PM
06:01AM
05:00AM
Oct-30-23 03:46PM
08:30AM
Oct-25-23 01:45AM
Oct-23-23 07:38AM
06:30AM
Oct-10-23 09:45AM
Sep-27-23 07:49AM
Sep-26-23 06:30AM
Sep-21-23 04:05PM
Sep-18-23 06:30AM
Aug-31-23 10:30AM
Aug-11-23 09:10AM
Aug-10-23 07:50AM
06:40AM
06:30AM
Aug-03-23 06:30AM
Jul-25-23 09:55AM
Jul-13-23 09:53AM
Jun-16-23 06:02AM
Jun-15-23 04:07PM
06:30AM
Jun-09-23 08:02AM
Jun-01-23 06:30AM
May-23-23 06:30AM
May-15-23 07:45AM
06:36AM
06:30AM
May-11-23 07:21AM
May-09-23 06:30AM
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ashe Andrew D.See RemarksMay 14 '24Buy6.2676,000475,760342,509May 15 05:30 PM
Nickerson JoanChief Administrative OfficerApr 02 '24Sale8.241,51412,4758,659Apr 03 05:00 PM
Dorval AllisonChief Financial OfficerNov 29 '23Sale11.455546,3434,060Dec 01 04:30 PM